ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Buckland
|
261 |
63K |
4 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
63K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Buckland
|
261 |
63K |
8 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
63K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Resignation of CEO
|
|
Buckland
|
4 |
1.4K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
4
|
1.4K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Buckland
|
100 |
26K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
100
|
26K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
3 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
3 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
1 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Buckland
|
1 |
693 |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
1
|
693
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Buckland
|
37 |
8.8K |
9 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.8K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Buckland
|
37 |
8.8K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.8K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Buckland
|
37 |
8.8K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.8K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech $6.4m Capital Raising
|
|
Buckland
|
362 |
106K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
362
|
106K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Buckland
|
317 |
79K |
5 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
317
|
79K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech $6.4m Capital Raising
|
|
Buckland
|
362 |
106K |
7 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
362
|
106K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech $6.4m Capital Raising
|
|
Buckland
|
362 |
106K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
362
|
106K
|
1
|
|
ASX - By Stock
|
NWC |
Re:
Ann: Trading Halt
|
|
Buckland
|
35 |
11K |
5 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
35
|
11K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Buckland
|
422 |
146K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
422
|
146K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
Buckland
|
422 |
146K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
422
|
146K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Buckland
|
9.1K |
2.7M |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
9.1K
|
2.7M
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
7 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech $6.4m Capital Raising
|
|
Buckland
|
362 |
106K |
15 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
362
|
106K
|
15
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech secures $1.4m Qld Grant Funding
|
|
Buckland
|
244 |
73K |
5 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
244
|
73K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech secures $1.4m Qld Grant Funding
|
|
Buckland
|
244 |
73K |
3 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
244
|
73K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Buckland
|
1.3K |
324K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
1.3K
|
324K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Buckland
|
66 |
18K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
18K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Buckland
|
66 |
18K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
18K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Buckland
|
66 |
18K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
18K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Trading Halt
|
|
Buckland
|
172 |
53K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
172
|
53K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Buckland
|
66 |
18K |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
18K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Trading Halt
|
|
Buckland
|
172 |
53K |
6 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
172
|
53K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Buckland
|
66 |
18K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
18K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Buckland
|
66 |
18K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
18K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech secures $1.4m Qld Grant Funding
|
|
Buckland
|
244 |
73K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
244
|
73K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Buckland
|
55 |
14K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
55
|
14K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Buckland
|
62 |
16K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
2024 - The year of ADO
|
|
Buckland
|
727 |
233K |
15 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
727
|
233K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Buckland
|
31 |
11K |
16 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
31
|
11K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Buckland
|
33 |
8.5K |
1 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
33
|
8.5K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Buckland
|
33 |
8.5K |
1 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
33
|
8.5K
|
1
|
|